SK Biopharmaceuticals announces completion of drug-development AI model pilot
SK Biopharmaceuticals announced it had completed pilot work for an AI foundation model project led by the Ministry of Science and ICT. The company said it built specialized drug-development training data comprising 7.14 million records and 4.4 billion tokens. It said model performance was evaluated against drug-development benchmarks and further tested using confidential pharmaceutical data, supporting its potential use in research.